Obstetrics/Gynecology · Miami Lakes, FL
NPI
1437323219
Since 2008
Specialty
Obstetrics/Gynecology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8145 NW 155th St, Suite B
Miami Lakes, FL, 33016
Phone (305) 698-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
182 services
Medicare patients, 2024
40
Average age 74
Drug cost, 2024
$309K
2,353 prescriptions
Company payments, 2025
$144
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge Pando was code 99214 (office e&m - established), 54 times for 29 patients. In total Jorge Pando billed 182 services in 29 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 54 | 29 | $97.51 | $5,266 |
| 99213 Office E&M - Established | Office | 18 | 16 | $63.35 | $1,140 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 16 | 16 | $45.06 | $721 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 15 | 15 | $42.41 | $636 |
By year: 2022 $22K for 147 services; 2023 $29K for 190 services; 2024 $22K for 182 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jorge Pando prescribed most often to Medicare patients was Oxybutynin Chloride Er (Oxybutynin Chloride), with 401 prescriptions and refills. In total Jorge Pando wrote 2,353 Medicare prescriptions that cost $309K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxybutynin Chloride Er Oxybutynin Chloride | 401 | 488 | 147 | $14K |
| Estradiol Generic | 310 | 1,199 | 191 | $21K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 271 | 319 | 86 | $46K |
| Myrbetriq Mirabegron | 236 | 265 | 86 | $118K |
| Oxybutynin Chloride Generic | 171 | 459 | 80 | $3,013 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 122 | 126 | 81 | $1,273 |
| Mirabegron Er Mirabegron | 70 | 70 | 26 | $22K |
| Solifenacin Succinate Generic | 67 | 71 | 21 | $9,224 |
| Clindamycin Phosphate Generic | 64 | 66 | 45 | $4,796 |
| Fluconazole Generic | 61 | 61 | 52 | $878 |
| Clobetasol Propionate Generic | 57 | 58 | 32 | $2,175 |
| Progesterone Progesterone, Micronized | 56 | 84 | 17 | $3,509 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 55 | 55 | 46 | $295 |
| Premarin Estrogens, Conjugated | 54 | 125 | 22 | $20K |
| Gemtesa Vibegron | 49 | 57 | 19 | $27K |
Brand drugs: - claims; generic drugs: 1,953 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge Pando $144 ($144 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $48.98.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.